Biogen
BIIB
#435
Rank
$39.04 B
Marketcap
$270.25
Share price
0.10%
Change (1 day)
27.67%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Operating Margin for Biogen (BIIB)

Operating Margin as of March 2023 (TTM): 35.30%

According to Biogen's latest financial reports and stock price the company's current Operating Margin is 35.30%. At the end of 2021 the company had an Operating Margin of 18.20%.

Operating Margin history for Biogen from 2001 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
202118.20%-53.57%
202039.20%-22.94%
201950.86%12.17%
201845.34%3.46%
201743.83%-3.37%
201645.36%0.4%
201545.18%10.25%
201440.98%13.06%
201336.24%5.7%
201234.29%-0.75%
201134.55%28.71%
201026.84%-14.14%
200931.26%6.67%
200829.31%-2.26%
200729.99%13.87%
200626.33%69.75%
200515.51%198.31%
20045.20%-104.08%
2003-127.42%-622.34%
200224.39%-29.34%
200134.52%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
24.28%-31.22%๐Ÿ‡บ๐Ÿ‡ธ USA
29.90%-15.30%๐Ÿ‡บ๐Ÿ‡ธ USA
23.21%-34.25%๐Ÿ‡บ๐Ÿ‡ธ USA
27.90%-20.96%๐Ÿ‡บ๐Ÿ‡ธ USA
19.90%-43.63%๐Ÿ‡ซ๐Ÿ‡ท France
21.31%-39.63%๐Ÿ‡บ๐Ÿ‡ธ USA
19.53%-44.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-84.50%-339.38%๐Ÿ‡บ๐Ÿ‡ธ USA
27.79%-21.27%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-279.56%-891.95%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.